Brief analysis of the institute of exhaustion of rights: the case of medicines
DOI:
10.16928/2316-8080.v5n1p.112-139Keywords:
TRIPS Exhaustion of rights Parallel imports Pharmaceutical product Pharmaceutical industryAbstract
This article aims to present some brief clarifications around the exhaustion of intellectual property rights, especially when the object of exhaustion are patented pharmaceutical products, as well as intends to demonstrate the importance of the exhaustion principle to the market equilibrium. The study of the peculiarities inherent to the exhaustion of intellectual property rights is essential to the visualization and selection of the system that best satisfies the general interests and the possibility (or not) of parallel imports of goods protected by such intellectual property rights.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain copyright in their work and grant the journal the right of first publication. The licence applicable to this article is the one stated on its own page and corresponds to the policy in force on its date of publication.
Authors are permitted to deposit the published version in institutional and subject repositories, provided the original publication in this journal is acknowledged.
PIDCC charges no submission, processing or publication fees.